Comparing Follow-Up Scans After Sarcoma Surgery
Part of Cancer clinical trials.
This trial compares two different schedules of follow-up scans after surgery for retroperitoneal sarcoma. The goal is to see if less frequent scanning is just as safe and effective as more frequent scanning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had surgery to remove a retroperitoneal, abdominal, or pelvic soft tissue sarcoma for the first time.
- All visible tumor was removed (R0 or R1 resection).
- At the time of joining the study, there is no sign that the cancer has spread to other parts of the body.
- You are not receiving any additional treatment that would interfere with regular follow-up scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This trial compares two schedules of post-treatment check-ups to see which one better supports patient quality of life. You’d fill out surveys for up to two years to measure how you feel over time.
This study follows adults who have had surgery for a retroperitoneal sarcoma. It collects clinical and imaging information after treatment to better understand outcomes and guide future care.
This study compares two ways to monitor your lungs after surgery for a high-risk soft tissue sarcoma: chest CT scans versus chest X-rays. The goal is to see if one method is better at finding any return of cancer early, so you can get the right follow-up care.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
Hear when a new Sarcoma,Soft Tissue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.